ReShape Lifesciences Inc (NASDAQ: RSLS) announced today that it has arrived at a security exercise contract with currently qualified stakeholders to exercise definite unresolved warrants to obtain up to a collective of 7.9 million shares of the company’s common stock. Exercising owners obtained new unregistered certifications to acquisition up to […]